Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Why does arthritis return after cancer immunotherapy?

To better understand why inflammation recurs, researchers examined what changed inside the joints between initial and subsequent flares.

Why does arthritis return after cancer immunotherapy?

A new study published in Cancer Immunology Research explores why arthritis returns after cancer immunotherapy. The research, led by Sang Taek Kim from Yale School of Medicine, found that during subsequent flares of inflammatory arthritis, certain groups of immune cells present during the first flare become more numerous. This suggests that the immune system may be drawing on its memory of the earlier response, which could lead to recurrence of joint inflammation.

The study focused on patients who received immune checkpoint inhibitors, a type of cancer immunotherapy drug that removes restraints on T cells, allowing them to attack tumors more effectively. However, this immune response can also inflame healthy tissues, including the joints. The researchers used various sequencing techniques to examine active genes in individual cells and track groups of T cells that mediated joint inflammation.

The findings suggest that PD-1hi CXCL13hi CD4+T cells and effector CD8+T cells from the first flare grew in number by the second flare, potentially driving inflammation in the joints and playing a role in recurrence. The study aims to identify triggers of this recurrence and investigate whether these T cells can also be found in blood.

If further studies confirm this, a blood test could help doctors identify patients whose arthritis is more likely to return, potentially enabling the development of therapies that ease joint inflammation while preserving the immune system's ability to fight cancer.

Brief written by urgent.news from Futurity's own syndicated text. Machine-written; may contain errors — check the original.

Read the original at futurity.org →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →